Login / Signup

Subcutaneous hematomas from prophylactic heparin use.

Abhilash KoratalaDeepti Bhattacharya
Published in: Clinical case reports (2017)
Heparin is an anticoagulant, which is frequently used in hospitalized patients for prophylaxis of deep vein thrombosis (DVT). Subcutaneous administration of heparin may lead to complications such as bruising, hematoma, and pain at the injection site. Hematomas can develop without visible bruising, as in our case.
Keyphrases
  • venous thromboembolism
  • growth factor
  • chronic pain
  • pain management
  • atrial fibrillation
  • neuropathic pain
  • risk factors
  • ultrasound guided